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ABSTRACT 
 
 In this report we describe a rare presentation of Miller Fisher syndrome, a variant of Guillain Barre Syndrome. This 
distinctive syndrome is an acute immune mediated neuropathies usually preceded by an infectious illness 
characterized by total external ophthalmoplegia, severe ataxia and tendon areflexia. The presence of the IgG anti-
GQ1b antibody in serum   is an excellent diagnostic marker for MFS. This antibody often cross reacts with GT1a 
and is patho physiologically associated with ophthalmoplegia or ataxia in MFS and GBS. 
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CASE REPORT  
We report case of 50 year old female who presented with 
complaints drooping of both upper eyelids, diplopia, and 
swaying of body on either side while walking for last 7 
days. Patient also gave history of nasal intonation of 
voice since 3 days.  On general physical examination 
patient had Normal vitals.[1] Her central nervous system 
showed normal higher mental functions and fundus 
examination was normal.Patient had bilateral ptosis; 
bilateral dilated pupils with absent light, consensual and 
accommodation reflex. She also had loss of extra ocular 
movements in all directions(Fig1) 
 
. 
 
 
Figure 1: Patient with bilateral ptosis; bilateral dilated pupils with absent light, consensual and accommodation 
reflex, loss of extra ocular movements in all directions 
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Power of muscles at various joints in both upper and 
lower limb was normal but she had hypotonia and 
areflexia in all limbs. Plantars were bilaterally mute. Rest 
systemic examination was normal. 
Investigations: Routine baseline investigation like renal 
function test, liver function test and  serum electrolytes 
were normal. She was retroviral and VDRL Negative. 
ECG and 2D Echo, CT scan head were normal.  CSF 
analysis was normal. Nerve conduction study:  
 Motor – Normal; Sensory – All nerve has absent 
SNAP`s.  Anti Gq1b antibody was present (Fig 2) 
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Figure 2:Representation of Miller Fisher syndrome 
 
As per the history, examination and investigation 
findings the diagnosis of Miller Fisher Syndrome was 
made and treatments started with –5 cycle of 
Plasmapheresis which were given every alternate day for 
a period of 12 days. Patient gradually improved, ptosis 
slightly decreased and started walking after 2nd plasma 
pheresis with no swaying. 
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DISCUSSION  
In miller fisher syndrome Serial neurophysiologic 
studies have shown involvement of peripheral nerve, 
with prolonged peripheral conduction in the blink reflex 
arc[2]. MFS has emerged as the archetypal anti 
ganglioside antibody mediated immune neuropathy.3It is 
associated with acute phase IgG antibodies to Gq1B, 
Gt1A in over 90% of cases which are highly disease 
specific. In MFS serum anti ganglioside titres are at their 
peak at clinical presentation and decay rapidly, where 
ELISA test with tryptophan based chromatography 
shows a corrected optical density of > 0.1 which is 
considered as positive[4].MFS follows a wide variety of 
infections including campylobacter jejuni and upper 
respiratory viral tract infections. It follows the principle 
mimicry between Gq1B, Gt1A and C.Jejuni 
lipopolysaccharide and lipoligosaccharide core 
oligosaccharides as central to induction of this response, 
hence also termed as Anti Gq1B IgG Antibody 
syndrome. 5- 10 % of cases do not have any symptoms 
of any preceding infections such as C.Jejuni 
eneteritis[5].The sera with Anti Gq1B antibodies causes 
a reversible failure of Ach release from presynaptic 
motor nerve terminals. Since only 5% incidences of MFS 
with Anti Gq1B positive cases reported in india, proper 
evaluation helps in diagnosing and treating this 
condition[6]. 
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